Highest development stage: Phase 3

Development status: Active

Gram-positive activity

Combination therapy

Mechanism of Action/Target pathogen: Hospital-acquired bacterial pneumonia

Additional information: http://www.abstractsonline.com/plan/ViewAbstract.aspx?mID=3798&sKey=37b09dcf-f2b5-4e67-aa0d-3f43f3fc4972&cKey=2bb13110-2886-4fde-9b57-5c4fd53689ff&mKey=7a574a80-eab1-4b50-b343-4695df14907e